5xh7 - Revision history

OCA at 08:02, 22 November 2023

2023-11-22T08:02:06Z

←Older revision		Revision as of 08:02, 22 November 2023
Line 1:		Line 1:

	==Crystal structure of the Acidaminococcus sp. BV3L6 Cpf1 RR variant in complex with crRNA and target DNA (TCCA PAM)==		==Crystal structure of the Acidaminococcus sp. BV3L6 Cpf1 RR variant in complex with crRNA and target DNA (TCCA PAM)==
-	<StructureSection load='5xh7' size='340' side='right' caption='[[5xh7]], [[Resolution\|resolution]] 2.00Å' scene=''>	+	<StructureSection load='5xh7' size='340' side='right'caption='[[5xh7]], [[Resolution\|resolution]] 2.00Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5xh7]] is a 4 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Acisb Acisb~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5XH7 OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5XH7 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5xh7]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Acidaminococcus_sp._BV3L6 Acidaminococcus sp. BV3L6]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5XH7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5XH7 FirstGlance]. <br>
-	</td></tr><tr id='~~ligand~~'><td class="sblockLbl"><b>[[~~Ligand~~\|~~Ligands~~:]]</b></td><td class="sblockDat"~~><scene name~~=~~'pdbligand=CL:CHLORIDE+ION'>CL</scene~~>, ~~<scene name='pdbligand=EDO:1,~~2~~-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>~~</td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2Å</td></tr>
-	<tr id='~~related~~'><td class="sblockLbl"><b>[[~~Related_structure~~\|~~Related~~:]]</b></td><td class="sblockDat">~~[[5xh6\|5xh6]]~~<~~/td~~></tr>	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr>
-	<~~tr id~~='~~gene~~'><~~td class="sblockLbl"~~><~~b>[[Gene\|Gene~~:~~]]</b~~></td>~~<td class="sblockDat">cpf1, HMPREF1246_0236 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1111120 ACISB])~~</td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5xh7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5xh7 OCA], [https://pdbe.org/5xh7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5xh7 RCSB], [https://www.ebi.ac.uk/pdbsum/5xh7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5xh7 ProSAT]</span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5xh7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5xh7 OCA], [~~http~~://pdbe.org/5xh7 PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5xh7 RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5xh7 PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5xh7 ProSAT]</span></td></tr>	+
	</table>		</table>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/~~CPF1_ACISB CPF1_ACISB]~~] CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Has dsDNA endonuclease activity, results in a 4-base 5' ~~overhang~~ 19 and 22 bases downstream of the PAM on the non-targeted and targeted strand respectively (PubMed:26422227). In this CRISPR system correct processing of pre-crRNA requires only this protein and the CRISPR locus (By similarity).[UniProtKB:A0Q7Q2]<ref>PMID:26422227</ref>	+	[https://www.uniprot.org/uniprot/CS12A_ACISB CS12A_ACISB] CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Recognizes a short motif in the CRISPR repeat sequences (the 5' PAM or protospacer adjacent motif, TTTN in this organism) to help distinguish self versus nonself, as targets within the bacterial CRISPR locus do not have PAMs (PubMed:26422227). Has dsDNA endonuclease activity, results in staggered 4-base 5' overhangs 19 and 22 bases downstream of the PAM on the non-targeted and targeted strand respectively (PubMed:26422227). Non-target strand cleavage by the RuvC domain is probably a prerequisite of target strand cleavage by the Nuc domain (PubMed:27114038). In this CRISPR system correct processing of pre-crRNA requires only this protein and the CRISPR locus (By similarity).[UniProtKB:A0Q7Q2]<ref>PMID:26422227</ref> <ref>PMID:27114038</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 20:		Line 19:
	</div>		</div>
	<div class="pdbe-citations 5xh7" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 5xh7" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Endonuclease 3D structures\|Endonuclease 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Acisb~~]]	+	[[Category: Acidaminococcus sp. BV3L6]]
-	[[Category: Ishitani, R]]	+	[[Category: Large Structures]]
-	[[Category: Nishimasu, H]]	+	[[Category: Ishitani R]]
-	[[Category: Nureki, O]]	+	[[Category: Nishimasu H]]
-	[[Category: Yamano, T]]	+	[[Category: Nureki O]]
-	~~[[Category: Hydrolase-rna-dna complex]]~~	+	[[Category: Yamano T]]
-	~~[[Category: Nuclease~~]]	+

OCA at 06:17, 16 November 2017

2017-11-16T06:17:05Z

←Older revision		Revision as of 06:17, 16 November 2017
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 5xh7 is ~~ON HOLD~~ ~~until Paper~~ Publication	+	==Crystal structure of the Acidaminococcus sp. BV3L6 Cpf1 RR variant in complex with crRNA and target DNA (TCCA PAM)==
		+	<StructureSection load='5xh7' size='340' side='right' caption='[[5xh7]], [[Resolution\|resolution]] 2.00Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[5xh7]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Acisb Acisb]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5XH7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5XH7 FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5xh6\|5xh6]]</td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">cpf1, HMPREF1246_0236 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1111120 ACISB])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5xh7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5xh7 OCA], [http://pdbe.org/5xh7 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5xh7 RCSB], [http://www.ebi.ac.uk/pdbsum/5xh7 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5xh7 ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/CPF1_ACISB CPF1_ACISB]] CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Has dsDNA endonuclease activity, results in a 4-base 5' overhang 19 and 22 bases downstream of the PAM on the non-targeted and targeted strand respectively (PubMed:26422227). In this CRISPR system correct processing of pre-crRNA requires only this protein and the CRISPR locus (By similarity).[UniProtKB:A0Q7Q2]<ref>PMID:26422227</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	The RNA-guided Cpf1 nuclease cleaves double-stranded DNA targets complementary to the CRISPR RNA (crRNA), and it has been harnessed for genome editing technologies. Recently, Acidaminococcus sp. BV3L6 (AsCpf1) was engineered to recognize altered DNA sequences as the protospacer adjacent motif (PAM), thereby expanding the target range of Cpf1-mediated genome editing. Whereas wild-type AsCpf1 recognizes the TTTV PAM, the RVR (S542R/K548V/N552R) and RR (S542R/K607R) variants can efficiently recognize the TATV and TYCV PAMs, respectively. However, their PAM recognition mechanisms remained unknown. Here we present the 2.0 A resolution crystal structures of the RVR and RR variants bound to a crRNA and its target DNA. The structures revealed that the RVR and RR variants primarily recognize the PAM-complementary nucleotides via the substituted residues. Our high-resolution structures delineated the altered PAM recognition mechanisms of the AsCpf1 variants, providing a basis for the further engineering of CRISPR-Cpf1.

-	~~Authors: Nishimasu~~, H., Yamano, T., ~~Ishitani~~, R., Nureki, O.	+	Structural Basis for the Altered PAM Recognition by Engineered CRISPR-Cpf1.,Nishimasu H, Yamano T, Gao L, Zhang F, Ishitani R, Nureki O Mol Cell. 2017 Jul 6;67(1):139-147.e2. doi: 10.1016/j.molcel.2017.04.019. Epub, 2017 Jun 6. PMID:28595896<ref>PMID:28595896</ref>

-	~~Description: Crystal structure~~ of the ~~Acidaminococcus sp~~. ~~BV3L6 Cpf1 RR variant in complex with crRNA and target DNA (TCCA PAM)~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased Structures~~]]	+	</div>
		+	<div class="pdbe-citations 5xh7" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Acisb]]
		+	[[Category: Ishitani, R]]
		+	[[Category: Nishimasu, H]]
	[[Category: Nureki, O]]		[[Category: Nureki, O]]
	[[Category: Yamano, T]]		[[Category: Yamano, T]]
-	[[Category: ~~Nishimasu, H~~]]	+	[[Category: Hydrolase-rna-dna complex]]
-	[[Category: ~~Ishitani, R~~]]	+	[[Category: Nuclease]]

OCA at 14:48, 17 May 2017

2017-05-17T14:48:50Z

←Older revision		Revision as of 14:48, 17 May 2017
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5xh7 is ON HOLD	+	The entry 5xh7 is ON HOLD until Paper Publication

	Authors: Nishimasu, H., Yamano, T., Ishitani, R., Nureki, O.		Authors: Nishimasu, H., Yamano, T., Ishitani, R., Nureki, O.

OCA: Protected "5xh7" [edit=sysop:move=sysop]

2017-04-27T13:04:40Z

Protected "5xh7" [edit=sysop:move=sysop]

←Older revision

Revision as of 13:04, 27 April 2017

OCA: New page: '''Unreleased structure''' The entry 5xh7 is ON HOLD Authors: Nishimasu, H., Yamano, T., Ishitani, R., Nureki, O. Description: Crystal structure of the Acidaminococcus sp. BV3L6 Cpf1 R...

2017-04-27T13:04:39Z

New page: '''Unreleased structure''' The entry 5xh7 is ON HOLD Authors: Nishimasu, H., Yamano, T., Ishitani, R., Nureki, O. Description: Crystal structure of the Acidaminococcus sp. BV3L6 Cpf1 R...

New page

'''Unreleased structure'''

The entry 5xh7 is ON HOLD

Authors: Nishimasu, H., Yamano, T., Ishitani, R., Nureki, O.

Description: Crystal structure of the Acidaminococcus sp. BV3L6 Cpf1 RR variant in complex with crRNA and target DNA (TCCA PAM)
[[Category: Unreleased Structures]]
[[Category: Nureki, O]]
[[Category: Yamano, T]]
[[Category: Nishimasu, H]]
[[Category: Ishitani, R]]